Tag: drug development incentives

Orphan Drug Exclusivity: How Rare-Disease Medicines Get Market Protection

Learn how orphan drug exclusivity protects rare-disease medicines in the US and EU. Discover the 7-year market protection rules, the 'dyad' concept, and how it differs from patents.